|Articles|July 25, 2019

Comparison of pharmacologic agents to treat GDM

Insulin or an oral antihyperglycemic agent? Get the expert information you need to make the correct call.

A survey of MFM specialists published in 2017 reported that 57% use glyburide as their first-line treatment for gestational diabetes mellitus (GDM), 36% use insulin and 4% use metformin.

Read more on hyperglycemia in gestational diabetes: Using oral antidiabetic agents to manage hyperglycemia in GDM

References:

Bimson BE, Rosenn BM, Morris SA, Sasso EB, Schwartz RA, Brustman LE. Current trends in the diagnosis and management of gestational diabetes mellitus in the United States. J Matern Fetal Neonatal Med. 2017;30(21):2607-2612.

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related to this article

October 29th, 2026

Susan Reed, MD, on the future of menopause research and funding

Susan Reed, MD, on the need for menopause research funding, a clinical trials network, and studies in understudied groups and perimenopause.

October 29th, 2026

Chrisandra Shufelt, MD, on cardiovascular prevention at menopause

Chrisandra Shufelt, MD, on why menopause is a window for cardiovascular prevention and the risk factors OB/GYNs should assess.

October 28th, 2026

Matthew Nudy, MD, on estrogen and the cardiovascular system

Matthew Nudy, MD, on estrogen's cardiovascular effects, risk assessment, and hormone therapy safety in younger menopausal women.

October 28th, 2026

ACOG advises against GLP-1 receptor agonists during pregnancy

ACOG advises against GLP-1 receptor agonists in pregnancy and recommends considering discontinuation 1 to 2 months before conception.

October 27th, 2026

Rhonda Voskuhl, MD, on estriol for cognitive symptoms of menopause

Rhonda Voskuhl, MD, on a case series in which estriol and progesterone improved self-reported cognition in menopausal women at 12 months.

October 27th, 2026

Multi-society framework ties cardiovascular risk to female life stages

Joint guidance from the AHA, AAP, ACOG, and SMFM organizes cardiovascular prevention for girls and women around 4 female life stages.

October 26th, 2026

Mind, Body, & the Pause: Menopause, brain fog, and screening gaps, with Manisha Parulekar, MD, and Jocelyn Carlo, MD, FACOG

In the premiere episode of Mind, Body, & the Pause, Soma Mandal, MD, is joined by Manisha Parulekar, MD, and Jocelyn Carlo, MD, FACOG, to discuss the stages of the menopause transition.